O'Callaghan, F., & Rating, D. (2018). Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial. The lancet child & adolescent health, 2(10), . https://doi.org/10.1016/S2352-4642(18)30244-X
Chicago-Zitierstil (17. Ausg.)O'Callaghan, Finbar, und Dietz Rating. "Vigabatrin with Hormonal Treatment Versus Hormonal Treatment Alone (ICISS) for Infantile Spasms: 18-month Outcomes of an Open-label, Randomised Controlled Trial." The Lancet Child & Adolescent Health 2, no. 10 (2018). https://doi.org/10.1016/S2352-4642(18)30244-X.
MLA-Zitierstil (9. Ausg.)O'Callaghan, Finbar, und Dietz Rating. "Vigabatrin with Hormonal Treatment Versus Hormonal Treatment Alone (ICISS) for Infantile Spasms: 18-month Outcomes of an Open-label, Randomised Controlled Trial." The Lancet Child & Adolescent Health, vol. 2, no. 10, 2018, https://doi.org/10.1016/S2352-4642(18)30244-X.